APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sleep Disorder Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sleep Disorder Treatment Drugs Market Outlook and Growth Opportunities 2026

22 December 2025216 pages

Choose your research edition.

Industry ResearchSleep Disorder Treatment Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Sleep Disorder Treatment Drugs Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Sleep Disorder Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sleep Disorder Treatment Drugs Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Sleep Disorder Treatment Drugs Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Sleep Disorder Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sleep Disorder Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sleep Disorder Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sleep Disorder Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sleep Disorder Treatment Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sleep Disorder Treatment Drugs market include Takeda Pharmaceutical Company, Eisai, Teva Pharmaceutical Industries Ltd., Sanofi, Merck, Pfizer, GlaxoSmithKline, ZYDUS CADILA GROUP and Natus Medicalorporated, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sleep Disorder Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sleep Disorder Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sleep Disorder Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sleep Disorder Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Sleep Disorder Treatment Drugs Segment by Company

Takeda Pharmaceutical Company

Eisai

Teva Pharmaceutical Industries Ltd.

Sanofi

Merck

Pfizer

GlaxoSmithKline

ZYDUS CADILA GROUP

Natus Medicalorporated

Mylan N.V.

Leva Pharmaceutical Industries

Koninklijke Philips

Heptares Therapeutics (Sosei Group Corporation)

Galenica

Ferring International Center

Evotec

Cardinal Health

Becton Dickson and Company

Athenex

Astellas Pharma

Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)

Sleep Disorder Treatment Drugs Segment by Type

Herbal Drugs

Prescription-based Drugs

OTC Drugs

Sleep Disorder Treatment Drugs Segment by Application

Clinics

Hospitals

Research Centers

Others

Sleep Disorder Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sleep Disorder Treatment Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sleep Disorder Treatment Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sleep Disorder Treatment Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Sleep Disorder Treatment Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sleep Disorder Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sleep Disorder Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sleep Disorder Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sleep Disorder Treatment Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sleep Disorder Treatment Drugs industry.

Chapter 3: Detailed analysis of Sleep Disorder Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sleep Disorder Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sleep Disorder Treatment Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sleep Disorder Treatment Drugs Industry Trends Table 2. Sleep Disorder Treatment Drugs Industry Drivers Table 3. Sleep Disorder Treatment Drugs Industry Opportunities and Challenges Table 4. Sleep Disorder Treatment Drugs Industry Restraints Table 5. Global Sleep Disorder Treatment Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sleep Disorder Treatment Drugs Revenue Share by Company (2021-2026) Table 7. Global Sleep Disorder Treatment Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Sleep Disorder Treatment Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Sleep Disorder Treatment Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Sleep Disorder Treatment Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sleep Disorder Treatment Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Sleep Disorder Treatment Drugs Company, Product Type & Application Table 13. Global Sleep Disorder Treatment Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sleep Disorder Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Herbal Drugs Table 18. Significant Companies of Prescription-based Drugs Table 19. Significant Companies of OTC Drugs Table 20. Global Sleep Disorder Treatment Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Sleep Disorder Treatment Drugs Sales Volume by Type (2021-2026) & (k units) Table 22. Global Sleep Disorder Treatment Drugs Sales Volume by Type (2027-2032) & (k units) Table 23. Global Sleep Disorder Treatment Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Sleep Disorder Treatment Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Sleep Disorder Treatment Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sleep Disorder Treatment Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Sleep Disorder Treatment Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Sleep Disorder Treatment Drugs Sales Value Share by Type (2021-2026) Table 29. Global Sleep Disorder Treatment Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Clinics Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Research Centers Table 33. Significant Companies of Others Table 34. Global Sleep Disorder Treatment Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Sleep Disorder Treatment Drugs Sales Volume by Application (2021-2026) & (k units) Table 36. Global Sleep Disorder Treatment Drugs Sales Volume by Application (2027-2032) & (k units) Table 37. Global Sleep Disorder Treatment Drugs Sales Volume Share by Application (2021-2026) Table 38. Global Sleep Disorder Treatment Drugs Sales Volume Share by Application (2027-2032) Table 39. Global Sleep Disorder Treatment Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Sleep Disorder Treatment Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Sleep Disorder Treatment Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Sleep Disorder Treatment Drugs Sales Value Share by Application (2021-2026) Table 43. Global Sleep Disorder Treatment Drugs Sales Value Share by Application (2027-2032) Table 44. Global Sleep Disorder Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Sleep Disorder Treatment Drugs Sales by Region (2021-2026) & (k units) Table 46. Global Sleep Disorder Treatment Drugs Sales Market Share by Region (2021-2026) Table 47. Global Sleep Disorder Treatment Drugs Sales by Region (2027-2032) & (k units) Table 48. Global Sleep Disorder Treatment Drugs Sales Market Share by Region (2027-2032) Table 49. Global Sleep Disorder Treatment Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Sleep Disorder Treatment Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Sleep Disorder Treatment Drugs Sales Value Share by Region (2021-2026) Table 52. Global Sleep Disorder Treatment Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Sleep Disorder Treatment Drugs Sales Value Share by Region (2027-2032) Table 54. Global Sleep Disorder Treatment Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Sleep Disorder Treatment Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Sleep Disorder Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Sleep Disorder Treatment Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 59. Global Sleep Disorder Treatment Drugs Sales Market Share by Country (2021-2026) Table 60. Global Sleep Disorder Treatment Drugs Sales by Country (2027-2032) & (k units) Table 61. Global Sleep Disorder Treatment Drugs Sales Market Share by Country (2027-2032) Table 62. Global Sleep Disorder Treatment Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Sleep Disorder Treatment Drugs Sales Value Market Share by Country (2021-2026) Table 64. Global Sleep Disorder Treatment Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Sleep Disorder Treatment Drugs Sales Value Market Share by Country (2027-2032) Table 66. Takeda Pharmaceutical Company Company Information Table 67. Takeda Pharmaceutical Company Business Overview Table 68. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Product Portfolio Table 70. Takeda Pharmaceutical Company Recent Development Table 71. Eisai Company Information Table 72. Eisai Business Overview Table 73. Eisai Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Eisai Sleep Disorder Treatment Drugs Product Portfolio Table 75. Eisai Recent Development Table 76. Teva Pharmaceutical Industries Ltd. Company Information Table 77. Teva Pharmaceutical Industries Ltd. Business Overview Table 78. Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Product Portfolio Table 80. Teva Pharmaceutical Industries Ltd. Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sanofi Sleep Disorder Treatment Drugs Product Portfolio Table 85. Sanofi Recent Development Table 86. Merck Company Information Table 87. Merck Business Overview Table 88. Merck Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Merck Sleep Disorder Treatment Drugs Product Portfolio Table 90. Merck Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Pfizer Sleep Disorder Treatment Drugs Product Portfolio Table 95. Pfizer Recent Development Table 96. GlaxoSmithKline Company Information Table 97. GlaxoSmithKline Business Overview Table 98. GlaxoSmithKline Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. GlaxoSmithKline Sleep Disorder Treatment Drugs Product Portfolio Table 100. GlaxoSmithKline Recent Development Table 101. ZYDUS CADILA GROUP Company Information Table 102. ZYDUS CADILA GROUP Business Overview Table 103. ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Product Portfolio Table 105. ZYDUS CADILA GROUP Recent Development Table 106. Natus Medicalorporated Company Information Table 107. Natus Medicalorporated Business Overview Table 108. Natus Medicalorporated Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Natus Medicalorporated Sleep Disorder Treatment Drugs Product Portfolio Table 110. Natus Medicalorporated Recent Development Table 111. Mylan N.V. Company Information Table 112. Mylan N.V. Business Overview Table 113. Mylan N.V. Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Mylan N.V. Sleep Disorder Treatment Drugs Product Portfolio Table 115. Mylan N.V. Recent Development Table 116. Leva Pharmaceutical Industries Company Information Table 117. Leva Pharmaceutical Industries Business Overview Table 118. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Product Portfolio Table 120. Leva Pharmaceutical Industries Recent Development Table 121. Koninklijke Philips Company Information Table 122. Koninklijke Philips Business Overview Table 123. Koninklijke Philips Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Koninklijke Philips Sleep Disorder Treatment Drugs Product Portfolio Table 125. Koninklijke Philips Recent Development Table 126. Heptares Therapeutics (Sosei Group Corporation) Company Information Table 127. Heptares Therapeutics (Sosei Group Corporation) Business Overview Table 128. Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Product Portfolio Table 130. Heptares Therapeutics (Sosei Group Corporation) Recent Development Table 131. Galenica Company Information Table 132. Galenica Business Overview Table 133. Galenica Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Galenica Sleep Disorder Treatment Drugs Product Portfolio Table 135. Galenica Recent Development Table 136. Ferring International Center Company Information Table 137. Ferring International Center Business Overview Table 138. Ferring International Center Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Ferring International Center Sleep Disorder Treatment Drugs Product Portfolio Table 140. Ferring International Center Recent Development Table 141. Evotec Company Information Table 142. Evotec Business Overview Table 143. Evotec Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Evotec Sleep Disorder Treatment Drugs Product Portfolio Table 145. Evotec Recent Development Table 146. Cardinal Health Company Information Table 147. Cardinal Health Business Overview Table 148. Cardinal Health Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Cardinal Health Sleep Disorder Treatment Drugs Product Portfolio Table 150. Cardinal Health Recent Development Table 151. Becton Dickson and Company Company Information Table 152. Becton Dickson and Company Business Overview Table 153. Becton Dickson and Company Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Becton Dickson and Company Sleep Disorder Treatment Drugs Product Portfolio Table 155. Becton Dickson and Company Recent Development Table 156. Athenex Company Information Table 157. Athenex Business Overview Table 158. Athenex Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Athenex Sleep Disorder Treatment Drugs Product Portfolio Table 160. Athenex Recent Development Table 161. Astellas Pharma Company Information Table 162. Astellas Pharma Business Overview Table 163. Astellas Pharma Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Astellas Pharma Sleep Disorder Treatment Drugs Product Portfolio Table 165. Astellas Pharma Recent Development Table 166. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Company Information Table 167. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Business Overview Table 168. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Product Portfolio Table 170. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Recent Development Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Sleep Disorder Treatment Drugs Distributors List Table 174. Sleep Disorder Treatment Drugs Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Sleep Disorder Treatment Drugs Product Image Figure 2. Global Sleep Disorder Treatment Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sleep Disorder Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sleep Disorder Treatment Drugs Sales (2021-2032) & (k units) Figure 5. Global Sleep Disorder Treatment Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Sleep Disorder Treatment Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Herbal Drugs Image Figure 10. Prescription-based Drugs Image Figure 11. OTC Drugs Image Figure 12. Global Sleep Disorder Treatment Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Sleep Disorder Treatment Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Sleep Disorder Treatment Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Sleep Disorder Treatment Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Sleep Disorder Treatment Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Sleep Disorder Treatment Drugs Sales Value Share by Type (2021-2032) Figure 18. Clinics Image Figure 19. Hospitals Image Figure 20. Research Centers Image Figure 21. Others Image Figure 22. Global Sleep Disorder Treatment Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Sleep Disorder Treatment Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Sleep Disorder Treatment Drugs Sales Volume Share by Application (2021-2032) Figure 25. Global Sleep Disorder Treatment Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Sleep Disorder Treatment Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Sleep Disorder Treatment Drugs Sales Value Share by Application (2021-2032) Figure 28. Global Sleep Disorder Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Sleep Disorder Treatment Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Sleep Disorder Treatment Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Sleep Disorder Treatment Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Sleep Disorder Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. North America Sleep Disorder Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Sleep Disorder Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Sleep Disorder Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Sleep Disorder Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Sleep Disorder Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Sleep Disorder Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. South America Sleep Disorder Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Sleep Disorder Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Sleep Disorder Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Sleep Disorder Treatment Drugs Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Sleep Disorder Treatment Drugs Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Herbal Drugs
  • Prescription-based Drugs
  • OTC Drugs
Applications
  • Clinics
  • Hospitals
  • Research Centers
  • Others
Companies covered
  • Takeda Pharmaceutical Company
  • Eisai
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • ZYDUS CADILA GROUP
  • Natus Medicalorporated
  • Mylan N.V.
  • Leva Pharmaceutical Industries
  • Koninklijke Philips
  • Heptares Therapeutics (Sosei Group Corporation)
  • Galenica
  • Ferring International Center
  • Evotec
  • Cardinal Health
  • Becton Dickson and Company
  • Athenex
  • Astellas Pharma
  • Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sleep Disorder Treatment Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Sleep Disorder Treatment Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Sleep Disorder Treatment Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sleep Disorder Treatment Drugs Market Dynamics
  1. 2.1 Sleep Disorder Treatment Drugs Industry Trends
  2. 2.2 Sleep Disorder Treatment Drugs Industry Drivers
  3. 2.3 Sleep Disorder Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Sleep Disorder Treatment Drugs Industry Restraints
3 Sleep Disorder Treatment Drugs Market by Company
  1. 3.1 Global Sleep Disorder Treatment Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Sleep Disorder Treatment Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Sleep Disorder Treatment Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Sleep Disorder Treatment Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Sleep Disorder Treatment Drugs Company Ranking (2024-2026)
  6. 3.6 Global Sleep Disorder Treatment Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Sleep Disorder Treatment Drugs Company Product Type and Application
  8. 3.8 Global Sleep Disorder Treatment Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sleep Disorder Treatment Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sleep Disorder Treatment Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sleep Disorder Treatment Drugs Market by Type
  1. 4.1 Sleep Disorder Treatment Drugs Type Introduction
  2. 4.1.1 Herbal Drugs
  3. 4.1.2 Prescription-based Drugs
  4. 4.1.3 OTC Drugs
  5. 4.2 Global Sleep Disorder Treatment Drugs Sales Volume by Type
  6. 4.2.1 Global Sleep Disorder Treatment Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sleep Disorder Treatment Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Sleep Disorder Treatment Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Sleep Disorder Treatment Drugs Sales Value by Type
  10. 4.3.1 Global Sleep Disorder Treatment Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Sleep Disorder Treatment Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Sleep Disorder Treatment Drugs Sales Value Share by Type (2021-2032)
5 Sleep Disorder Treatment Drugs Market by Application
  1. 5.1 Sleep Disorder Treatment Drugs Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Research Centers
  5. 5.1.4 Others
  6. 5.2 Global Sleep Disorder Treatment Drugs Sales Volume by Application
  7. 5.2.1 Global Sleep Disorder Treatment Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Sleep Disorder Treatment Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Sleep Disorder Treatment Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Sleep Disorder Treatment Drugs Sales Value by Application
  11. 5.3.1 Global Sleep Disorder Treatment Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Sleep Disorder Treatment Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Sleep Disorder Treatment Drugs Sales Value Share by Application (2021-2032)
6 Sleep Disorder Treatment Drugs Regional Sales and Value Analysis
  1. 6.1 Global Sleep Disorder Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sleep Disorder Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Sleep Disorder Treatment Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Sleep Disorder Treatment Drugs Sales by Region (2027-2032)
  5. 6.3 Global Sleep Disorder Treatment Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sleep Disorder Treatment Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sleep Disorder Treatment Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sleep Disorder Treatment Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Sleep Disorder Treatment Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sleep Disorder Treatment Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Sleep Disorder Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sleep Disorder Treatment Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Sleep Disorder Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sleep Disorder Treatment Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sleep Disorder Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sleep Disorder Treatment Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Sleep Disorder Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sleep Disorder Treatment Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sleep Disorder Treatment Drugs Sales Value Share by Country, 2025 VS 2032
7 Sleep Disorder Treatment Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Sleep Disorder Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sleep Disorder Treatment Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sleep Disorder Treatment Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Sleep Disorder Treatment Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Sleep Disorder Treatment Drugs Sales by Country (2027-2032)
  6. 7.4 Global Sleep Disorder Treatment Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sleep Disorder Treatment Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sleep Disorder Treatment Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sleep Disorder Treatment Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sleep Disorder Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sleep Disorder Treatment Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company
  2. 8.1.1 Takeda Pharmaceutical Company Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 8.2 Eisai
  8. 8.2.1 Eisai Company Information
  9. 8.2.2 Eisai Business Overview
  10. 8.2.3 Eisai Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eisai Sleep Disorder Treatment Drugs Product Portfolio
  12. 8.2.5 Eisai Recent Developments
  13. 8.3 Teva Pharmaceutical Industries Ltd.
  14. 8.3.1 Teva Pharmaceutical Industries Ltd. Company Information
  15. 8.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
  16. 8.3.3 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Product Portfolio
  18. 8.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Sleep Disorder Treatment Drugs Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Sleep Disorder Treatment Drugs Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Sleep Disorder Treatment Drugs Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Sleep Disorder Treatment Drugs Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 ZYDUS CADILA GROUP
  44. 8.8.1 ZYDUS CADILA GROUP Company Information
  45. 8.8.2 ZYDUS CADILA GROUP Business Overview
  46. 8.8.3 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Product Portfolio
  48. 8.8.5 ZYDUS CADILA GROUP Recent Developments
  49. 8.9 Natus Medicalorporated
  50. 8.9.1 Natus Medicalorporated Company Information
  51. 8.9.2 Natus Medicalorporated Business Overview
  52. 8.9.3 Natus Medicalorporated Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Natus Medicalorporated Sleep Disorder Treatment Drugs Product Portfolio
  54. 8.9.5 Natus Medicalorporated Recent Developments
  55. 8.10 Mylan N.V.
  56. 8.10.1 Mylan N.V. Company Information
  57. 8.10.2 Mylan N.V. Business Overview
  58. 8.10.3 Mylan N.V. Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mylan N.V. Sleep Disorder Treatment Drugs Product Portfolio
  60. 8.10.5 Mylan N.V. Recent Developments
  61. 8.11 Leva Pharmaceutical Industries
  62. 8.11.1 Leva Pharmaceutical Industries Company Information
  63. 8.11.2 Leva Pharmaceutical Industries Business Overview
  64. 8.11.3 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Product Portfolio
  66. 8.11.5 Leva Pharmaceutical Industries Recent Developments
  67. 8.12 Koninklijke Philips
  68. 8.12.1 Koninklijke Philips Company Information
  69. 8.12.2 Koninklijke Philips Business Overview
  70. 8.12.3 Koninklijke Philips Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Koninklijke Philips Sleep Disorder Treatment Drugs Product Portfolio
  72. 8.12.5 Koninklijke Philips Recent Developments
  73. 8.13 Heptares Therapeutics (Sosei Group Corporation)
  74. 8.13.1 Heptares Therapeutics (Sosei Group Corporation) Company Information
  75. 8.13.2 Heptares Therapeutics (Sosei Group Corporation) Business Overview
  76. 8.13.3 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Product Portfolio
  78. 8.13.5 Heptares Therapeutics (Sosei Group Corporation) Recent Developments
  79. 8.14 Galenica
  80. 8.14.1 Galenica Company Information
  81. 8.14.2 Galenica Business Overview
  82. 8.14.3 Galenica Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Galenica Sleep Disorder Treatment Drugs Product Portfolio
  84. 8.14.5 Galenica Recent Developments
  85. 8.15 Ferring International Center
  86. 8.15.1 Ferring International Center Company Information
  87. 8.15.2 Ferring International Center Business Overview
  88. 8.15.3 Ferring International Center Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Ferring International Center Sleep Disorder Treatment Drugs Product Portfolio
  90. 8.15.5 Ferring International Center Recent Developments
  91. 8.16 Evotec
  92. 8.16.1 Evotec Company Information
  93. 8.16.2 Evotec Business Overview
  94. 8.16.3 Evotec Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Evotec Sleep Disorder Treatment Drugs Product Portfolio
  96. 8.16.5 Evotec Recent Developments
  97. 8.17 Cardinal Health
  98. 8.17.1 Cardinal Health Company Information
  99. 8.17.2 Cardinal Health Business Overview
  100. 8.17.3 Cardinal Health Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Cardinal Health Sleep Disorder Treatment Drugs Product Portfolio
  102. 8.17.5 Cardinal Health Recent Developments
  103. 8.18 Becton Dickson and Company
  104. 8.18.1 Becton Dickson and Company Company Information
  105. 8.18.2 Becton Dickson and Company Business Overview
  106. 8.18.3 Becton Dickson and Company Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Becton Dickson and Company Sleep Disorder Treatment Drugs Product Portfolio
  108. 8.18.5 Becton Dickson and Company Recent Developments
  109. 8.19 Athenex
  110. 8.19.1 Athenex Company Information
  111. 8.19.2 Athenex Business Overview
  112. 8.19.3 Athenex Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Athenex Sleep Disorder Treatment Drugs Product Portfolio
  114. 8.19.5 Athenex Recent Developments
  115. 8.20 Astellas Pharma
  116. 8.20.1 Astellas Pharma Company Information
  117. 8.20.2 Astellas Pharma Business Overview
  118. 8.20.3 Astellas Pharma Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Astellas Pharma Sleep Disorder Treatment Drugs Product Portfolio
  120. 8.20.5 Astellas Pharma Recent Developments
  121. 8.21 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)
  122. 8.21.1 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Company Information
  123. 8.21.2 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Business Overview
  124. 8.21.3 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Product Portfolio
  126. 8.21.5 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sleep Disorder Treatment Drugs Value Chain Analysis
  2. 9.1.1 Sleep Disorder Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sleep Disorder Treatment Drugs Sales Mode & Process
  6. 9.2 Sleep Disorder Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sleep Disorder Treatment Drugs Distributors
  9. 9.2.3 Sleep Disorder Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst